Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 32.70
+0.78 (2.44%)
Jun 18, 2026, 4:08 PM HKT
Ascentage Pharma Group International Employees
Ascentage Pharma Group International had 767 employees as of December 31, 2025. The number of employees increased by 200 or 35.27% compared to the previous year.
Employees
767
Change
200
Growth
35.27%
Revenue / Employee
832.97K HKD
Profits / Employee
-1.80M HKD
Market Cap
11.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 767 | 200 | 35.27% |
| Jun 30, 2025 | 605 | - | - |
| Dec 31, 2024 | 567 | -16 | -2.74% |
| Dec 31, 2023 | 583 | 3 | 0.52% |
| Dec 31, 2022 | 580 | -33 | -5.38% |
| Dec 31, 2021 | 613 | 180 | 41.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Everest Medicines | 812 |
| Suzhou Ribo Life Science | 407 |
| CARsgen Therapeutics Holdings | 355 |
| HBM Holdings | 272 |
| Ascletis Pharma | 202 |
Ascentage Pharma Group International News
- 3 days ago - Ascentage Pharma assumed with an Outperform at Oppenheimer - TheFly
- 3 days ago - Ascentage Pharma announces clinical updates from EHA2026 - TheFly
- 3 days ago - Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress - GlobeNewsWire
- 8 days ago - Ascentage Pharma initiated with a Buy at B. Riley - TheFly
- 17 days ago - Ascentage Pharma presents data on olverembatinib - TheFly
- 17 days ago - Ascentage Pharma presents data from Phase 1b study of olverembatinib - TheFly
- 17 days ago - Ascentage Pharma presents first dataset of alrizomadlin - TheFly
- 17 days ago - Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026 - GlobeNewsWire